VICIS - Vienna Cirrhosis Study
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18-100
SponsorMedical University of Vienna
About this trial
Patients with advanced chronic liver diseases treated at the Vienna General Hospital of the Medical University of Vienna will be offered to participate in this prospective observational trial - including an optional participation in a biobank.
Clinical parameters and laboratory parameters will be recorded for all patients and patients will undergo a regular follow-up schedule with clinical visits at the Vienna General Hospital.
This study is linked to a biobank with serum/plasma, ascitic fluid, urine, GI tract mucosal biopsies, liver biopsies and stool collected from the study participants.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
Age >18 years and <100 years
Diagnosis of advanced chronic liver disease (by liver stiffness ≥10kPa, HVPG>5mmHg or Histology F3/F4)
Written informed consent
Disqualifiers
Withdrawal of written informed consent
Trial population
Patient with advanced chronic liver disease diagnosed and/or treated at the Medical University of Vienna will be screened for inclusion/exclusion criteria.
Trial design
Design model
Cohort
Time perspective
Prospective
Treatments tested in this trial
Not listed
Trial groups
No trial groups listed
Trial outcomes
Primary outcomes
1
Transplant-free survival
Time from inclusion to death or liver transplantation
Time frame
01/FEB/2017 - 31/DECEMBER/2027Secondary outcomes
1
Decompensation-free survival
Time from inclusion to decompensation, death or liver transplantation
Time frame
01/FEB/2017 - 31/DECEMBER/2027Sponsors and contacts
Click on the lead sponsor to view all of their trials.
Source ClinicalTrials.gov